Knowledge, Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and… (NCT06743880) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Knowledge, Attitude &Practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
323 participantsStarted 2025-01-01
Plain-language summary
* Cervical cancer is caused by persistent infection with certain strains of the human papillomavirus (HPV), which is a very common virus transmitted through sexual activity.
* HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time.
* Cervical cancer is the second most common cancer among women in Egypt, after breast cancer.
* According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women.
* However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas.
The main objectives of this KAP study are:
1. To assess the level of knowledge about HPV and HPV vaccination among the target population.
2. To investigate the attitudes and perceptions towards HPV vaccination.
3. To identify the current practices and uptake of HPV vaccination.
4. To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.
Who can participate
Age range
9 Years – 79 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. general population:
* Eligibility criteria:
* Age: 9-79 years old
* patients and their relatives
* Attending the Obstetrics and Gynecology, or Family Medicine clinics at Assiut University Hospital
* Recruitment strategy:
* Using a systematic random sampling method, every nth patient (based on the average patient load) will be approached and invited to participate in the study.
* The target sample size for patients is a minimum of 384 participants.
2\. Healthcare providers:
* Eligibility criteria:
* Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.
Exclusion Criteria:
* -Previous HPV Vaccination:
* Exclude participants who have already received the complete HPV vaccination series, as their knowledge, attitudes, and practices may differ from those who are unvaccinated.
* The study aims to understand the KAP of the unvaccinated population, which is the primary target group for intervention.
2-Severe Cognitive or Mental Impairment:
* Exclude participants who have severe cognitive or mental impairments that may prevent them from understanding and responding to the questionnaire accurately.
* This could include individuals with advanced dementia, severe intellectual disabilities, or acute psychiatric conditions.
3-. Inability to Provide Informed Consent:
* Exclude participants who are unable to provide informed consent due to language barrie…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.